Special Report

Special Report By Erin Brodwin

Externally polished, internally marginalized: Inside the fight over Pinterest’s health misinformation policy

Special Report By Lev Facher

First-of-its-kind examination shows how widely pharma showers campaign cash at the state level

Special Report By Nicholas Florko

The 8 most important leaders of Operation Warp Speed

Special Report By Andrew Joseph

The Road Ahead: Charting the coronavirus pandemic over the next 12 months — and beyond

Special Report By Lev Facher

Ramped-up testing and daily briefings: Inside Biden’s plan to take over a tumultuous Covid-19 response

Special Report By Rebecca Robbins and Erin Brodwin

How Teladoc won: The inside story of how well-timed bets propelled it ahead of the competition

Special Report By Rebecca Robbins and Adam Feuerstein

Harry Reid and Alex Trebek tried Patrick Soon-Shiong’s experimental cancer therapy. Can their results be duplicated in a clinical trial?

Special Report By Rebecca Robbins and Erin Brodwin

An invisible hand: Patients aren’t being told about the AI systems advising their care

Special Report By David Barboza — The Wire

After a bribery scandal in China, GSK found a suspected whistleblower. The real one is still waiting in the shadows

Special Report By Megan Thielking

Facing a broken mental health system, many U.S. teens fall off a dangerous ‘cliff’ in their care

Special Report By Erin Brodwin and Casey Ross

Two years of halting progress and high turnover preceded Atul Gawande’s exit as Haven CEO

Special Report By Nicholas Florko and Damian Garde

With remdesivir, Gilead finds itself at strategic crossroads, with its reputation (and far more) at stake

Special Report By Gardiner Harris and Alex W. Palmer — The Wire

China has near-total control of the world’s antibiotic supply. Is America at risk as a result?

Special Report By Andrew Joseph

Coronavirus pandemic threatens to take crushing toll on rural areas, data show

Special Report By Sharon Begley

When can we let up? Health experts craft strategies to safely relax coronavirus lockdowns

Special Report By Andrew Joseph

As the coronavirus spreads, a drug that once raised the world’s hopes is given a second shot

Special Report By Megan Thielking

‘A Supercenter for health’: Walmart places a big bet on cheaper, less intimidating primary care

Special Report By Natasha Gilbert

‘Dump it down the drain’: How contaminants from prescription-drug factories pollute waterways

Special Report By Eric Boodman

The Medicine Hunters, Part II: Toxic weed fuels a cancer-drug gold rush — and a quandary

Special Report By Eric Boodman

The Medicine Hunters, Part I: Before signing up for a trial, one patient wants to know if the drug will be affordable

Special Report By Sharon Begley

Forecasting Alzheimer’s: With a tsunami of new diagnoses expected, experts calculate the best ways to shift the tide

Special Report By Diana Cai

Chinese scientists came to the U.S. to pursue their dreams. Under tighter scrutiny, many are returning home

Special Report By Eric Boodman

The vaccine whisperers: Counselors gently engage new parents before their doubts harden into certainty

Special Report By Nicholas Florko and Lev Facher

How pharma, under attack from all sides, keeps winning in Washington

Special Report By Sharon Begley

The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades